Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subjects: Conference, Trade Show, Webcast

Lineage Cell Therapeutics to Present at FORCE Wealth Virtual Fireside Chat on September 23, 2020


Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, announced today that Brian M. Culley, Chief Executive Officer, and Brandi L. Roberts, Chief Financial Officer, will be participating in a FORCE Wealth Virtual Fireside Chat on September 23, 2020 at 12:00 pm Eastern Time / 9:00 am Pacific Time. Jason McCarthy, Ph.D., Senior Managing Director, Biotechnology, Maxim Group, LLC will host the fireside chat with Lineage management.

Interested investors can access the live presentation on the Events and Presentations section of Lineage's website and archived presentations will be available for 30 days. Additional videos are available on the Media page of the Lineage website, located at www.lineagecell.com/media/.

About Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage's programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage's clinical programs are in markets with billion dollar opportunities and include three allogeneic ("off-the-shelf") product candidates: (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; and (iii) VAC, an allogeneic dendritic cell therapy platform for immuno-oncology and infectious disease, currently in clinical development for the treatment of non-small cell lung cancer and in preclinical development for additional cancers and as a vaccine against infectious diseases, including SARS-CoV-2, the virus which causes COVID-19. For more information, please visit www.lineagecell.com or follow the Company on Twitter @LineageCell.


These press releases may also interest you

at 08:00
Ryder System, Inc. , a leader in supply chain, dedicated transportation, and commercial fleet management solutions, reported results for the three months ended September 30 as follows: (In millions, except EPS) Earnings (Loss) Before Taxes...

at 07:57
Pathnostics, a diagnostic solutions company, today announced that it has launched a multiplex polymerise chain reaction (PCR) test that simultaneously detects multiple respiratory infections, including COVID-19, influenzas A/B and respiratory...

at 07:55
Giyani Metals Corp. ("Giyani" or the "Company") is pleased to announce that following the announcement made on August 26, 2020, Giyani has completed its responses to the submitted Scoping and Terms of Reference ("SToR") to the Botswana Department of...

at 07:55
The improper use and application of COVID-19 nasal swab PCR tests are endangering people's health, while rapid antibody tests are giving too many false negatives and delaying the reopening of American businesses. The United States economy is still...

at 07:50
Search Minerals Inc. ("Search" or the "Company") is pleased to report 2020 channel assay results from FOX MEADOW, a major mineralized zone in the Port Hope Simpson ? St. Lewis Critical Rare Earth Element (CREE) District. Trenching/channelling (four...

at 07:45
Escape Mail is now shipping its at-home escape room style adventure game to 20 countries around the world, transforming game night for eager players looking for something new, and giving people facing lockdown an affordable solution to the COVID...



News published on 17 september 2020 at 08:05 and distributed by: